These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17642012)

  • 1. Neisseria vaccines 2007 - international workshop.
    Martin D
    IDrugs; 2007 Jul; 10(7):450-2. PubMed ID: 17642012
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000.
    Cartwright K; Noah N; Peltola H;
    Vaccine; 2001 Aug; 19(31):4347-56. PubMed ID: 11534497
    [No Abstract]   [Full Text] [Related]  

  • 3. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
    Trotter CL; Ramsay ME
    FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multivalent conjugate vaccine for prevention of meningococcal disease in infants.
    Harrison LH
    JAMA; 2008 Jan; 299(2):217-9. PubMed ID: 18182606
    [No Abstract]   [Full Text] [Related]  

  • 6. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 7. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
    Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK
    Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease.
    Zuckerman JN; Bröker M; Worth C
    Travel Med Infect Dis; 2010 Mar; 8(2):68-73. PubMed ID: 20478511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease in US military personnel before and after adoption of conjugate vaccine.
    Broderick MP; Phillips C; Faix D
    Emerg Infect Dis; 2015 Feb; 21(2):377-9. PubMed ID: 25625525
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospects for vaccine prevention of meningococcal infection.
    Harrison LH
    Clin Microbiol Rev; 2006 Jan; 19(1):142-64. PubMed ID: 16418528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal C conjugate vaccination recommendations for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Nov; 33(ACS-11):1-12. PubMed ID: 18064747
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccines for the poor: meningococcal A conjugate vaccine in Africa.
    Isaacs D
    J Paediatr Child Health; 2011 Jan; 47(1-2):66. PubMed ID: 21255149
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccines against meningococcal disease: current and future technologies.
    Riddell A; Buttery J
    Expert Opin Biol Ther; 2001 May; 1(3):385-99. PubMed ID: 11727513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunisation update: Meningococcal B and ACWY vaccines.
    Davidson GT; Heaton PA; Paul SP
    J Fam Health; 2015; 25(6):22-5. PubMed ID: 26749934
    [No Abstract]   [Full Text] [Related]  

  • 15. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of MenACWY-CRM in adolescents in the United States.
    Black S; Block SL
    J Adolesc Health; 2013 Mar; 52(3):271-7. PubMed ID: 23299001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):273. PubMed ID: 20224545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on meningococcal C conjugate vaccines.
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2005 Apr; 31(ACS-3):1-4. PubMed ID: 15895508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Meningococcal disease and vaccines: still many questions and some answers].
    Godoy P; Castilla J; Astray J; Tuells J; Barrabeig I; Domínguez À
    Gac Sanit; 2020; 34(1):1-3. PubMed ID: 31767200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.